Market Signal Briefing

In a tumultuous week for the cryptocurrency market, investors witnessed a significant drop as approximately $19 billion was wiped off the market's total value. This dramatic decline has brought intense scrutiny on various digital assets, with some showing resilience while others faltered.

XRP is on the brink of a major breakthrough as ETF filings surge, regulatory hurdles shrink, institutional access expands, and investor anticipation reaches its highest level yet. XRP ETF Hype Builds as SEC Filings Suggest Imminent Launch Optimism is growing in the digital asset market amid rising expectations that the first U.S.

Grayscale's recent Ethereum staking move highlights the growing role of institutional investors in shaping the crypto market. As Ethereum trades near critical price levels, large-scale staking activity indicates that institutions are increasingly viewing ETH not just as a speculative asset, but as a core component of decentralized finance and Web3 infrastructure.

Cover image via www.freepik.com

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

The market is facing catastrophical consequences of the most recent price plummeting, and it's unclear whether we will go back to where most assets were trading or if they will plunge lower without a recovery possibility in the foreseeable future. 

Shiba Inu scratches bottomIn what seems to be the most severe collapse in the token’s recent history, Shiba Inu has officially dropped to its lowest level since early 2023. The meme coin, which was once the epitome of retail speculation, is currently in a deep structural weakness phase, with no fundamental or technical indications of a recovery in sight.

The price of SHIB finally gave in after tightening within a descending triangle for several months. It sliced through all significant support levels and broke below the $0.000010 mark. This decline wipes out almost all of the gains made over the previous two years and confirms a new annual low. The asset has essentially reached its historical support zone, which last served as a launching pad during the 2023 market cycle, with its current price hovering between $0.000009 and $0.000010.

HOT Stories

SHIB/USDT Chart by TradingViewHowever, the current climate is not as hopeful as it was in earlier cycles. Although the Relative Strength Index (RSI), which is positioned close to 30, indicates that SHIB is oversold, there is currently no discernible indication of accumulation or reversal, and trading volume is still low.

Shiba Inu’s delicate structure is further put under strain by the weakness of the overall market, which is exacerbated by macroeconomic uncertainty and waning speculative appetite. An ongoing downward slope of the 200-day moving average has confirmed a long-term bearish trend. Under it, the 50 and 100 EMAs have formed a full death cross, a pattern usually linked to prolonged downward movement.

Although it’s reasonable to assume that SHIB has probably reached its technical bottom at this time, a recovery is not necessarily imminent. Any brief rebound is likely to be met with selling pressure in the absence of new catalysts, robust on-chain activity, or renewed investor demand.

Bitcoin isn't strugglingBitcoin has once again shown its tenacity in the face of the recent meltdown that rocked the cryptocurrency market. Given the magnitude of the liquidation that affected the larger market, Bitcoin’s decline was remarkably contained, coming in at less than 10%, while many other altcoins experienced double-digit losses. Bitcoin’s dominance and fundamental structural strength are demonstrated by its ability to hold above the $110,000 mark.

The 200-day moving average (black line) at about $107,900, a historically significant level that has frequently served as a springboard during previous corrections, continues to provide strong support for the price, which has dropped significantly from its $124,000 local high on the daily chart. The technical structure is still positive. A medium-term bullish bias is maintained by the upward trending 50-day (orange) and 100-day (blue) moving averages.

With its current range of 41 to 59, the RSI indicates consolidation rather than breakdown, as momentum has cooled without going into a true bearish zone. On a larger scale, Bitcoin’s stability in the face of worldwide volatility is noteworthy. Even though ongoing equity drawdowns and tariff tensions have caused panic in riskier assets, Bitcoin still acts as a relative safe haven in the cryptocurrency space.

Even in uncertain times, its store-of-value positioning is highlighted by its smaller retracement when compared to Ethereum, Shiba Inu and other high-beta tokens. The lesson for investors is unmistakable: Bitcoin is still the gold standard. Market participants should concentrate on important support levels between $108,000 and $107,000 as well as possible upside recovery targets close to $118,000 and $122,000 during steep declines, rather than panic selling.

Healthy buying activity is seen in the vicinity of these zones, according to volume analysis, indicating that strong hands are building up. The crypto market appears battered, but Bitcoin’s relative strength indicates that the cycle is far from over. Bitcoin’s 10% decline is a pause in a longer, still-existing uptrend, not a collapse.

XRP takes plungeFirst, there are obvious indications of seller exhaustion in the price structure of XRP. Around $2.06, the asset fell below its 200-day moving average, but it quickly recovered with significant volume. Known as a flush and reclaim, this pattern implies that big buyers may have intervened to absorb panic-driven selling. Such XRP reclaim patterns have historically preceded 30% to 50% short-term rallies, which, if the momentum continues, would correspond with a move toward $1.

The second indicator of highly oversold conditions is the Relative Strength Index (RSI), which is presently trading close to 27. Every time XRP entered this zone in previous cycles, there was a multi-week recovery. RSI reversals from levels below 30 have frequently resulted in quick inflows of liquidity, especially when short sellers start to liquidate their holdings.

Third, a recovery thesis is supported by on-chain activity. The sharp increase in XRP’s ledger transactions and payment volume in recent days suggests that network activity increased even as prices fell. Price and utility divergence may encourage speculative optimism, which is a crucial component of cryptocurrency rebound rallies.

Macroeconomically, the market’s overreaction to international tariff tensions might also be stabilizing, which would support XRP’s recovery in tandem with Bitcoin’s relative strength.

XRP’s setup for a technical rebound toward $1 appears realistic, even though sentiment is still brittle. Traders should wait for confirmation above $2.8-$3.0 in order to confirm the breakout and get ready for a possible bullish reversal as soon as possible.

Tether CEO Paolo Ardoino has once again highlighted his bullish stance on Bitcoin and gold, declaring in a post on X that “Bitcoin and Gold will outlast any other currency.” The statement underscores the stablecoin issuer’s strategy of positioning these assets as key pillars of its reserve diversification plan.

Since May 2023, Tether has committed to allocating up to 15% of its net realized operating profits toward purchasing Bitcoin. The move was designed to strengthen the company’s balance sheet with a long-term store of value rather than backing USDT on a one-to-one basis. This strategy aligns with the company’s ongoing effort to enhance transparency and sustainability in its reserves.

Gold plays an equally important role in Tether’s portfolio. Through its product Tether Gold (XAUt), the firm offers tokens backed by physical gold bars. As of June 30, 2025, more than 7.66 tons of gold backed outstanding XAUt tokens. Furthermore, reports indicate that Tether has been exploring potential investments across the gold value chain — including mining, refining, and royalties — as part of a broader diversification initiative.

Ardoino has previously referred to Bitcoin, gold, and even land as hedge assets, emphasizing Tether’s long-term vision of financial resilience. Despite market speculation, he has denied claims that the company sold Bitcoin to buy gold, reaffirming its commitment to expanding its BTC holdings.

While Tether continues to hold most of its reserves in liquid instruments such as U.S. Treasurys, its growing exposure to Bitcoin and gold reflects a strategic shift toward tangible and decentralized assets. With Bitcoin up 22.79% and gold soaring 52.91% year-to-date, Ardoino’s latest statement reinforces Tether’s belief in these enduring assets as reliable stores of value amid global currency volatility.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

SoundHound AI (SOUN -6.49%) and BigBear.ai (BBAI -3.60%) represent two different ways to invest in the booming artificial intelligence (AI) market. SoundHound AI develops voice and audio recognition tools, while BigBear.ai's AI modules analyze data across edge networks.

Both companies went public by merging with special purpose acquisition companies (SPACs), and both stocks more than quadrupled over the past 12 months. Let's review the catalysts that drove these two AI stocks higher -- and whether either one is still worth buying in this frothy market.

Image source: Getty Images.

SoundHound is still growing like a weed
SoundHound AI's namesake app identifies songs from a few seconds of recorded audio or a few hummed bars. But it generates most of its revenue from Houndify, a developer platform that enables companies to produce their own AI-powered voice recognition services. Houndify's top customers include automakers such as Stellantis, quick-service restaurants like Chipotle, and credit card giants like Mastercard. It's a popular option for companies that don't want to share their data with big tech companies.

SoundHound's revenue rose 47% in 2023, 85% in 2024, and 187% year over year in the first half of 2025. That acceleration was impressive, but it was partly driven by its acquisitions of the AI restaurant services provider SYNQ3, the online food ordering platform Allset, and the conversational AI company Amelia.

Its integration of those acquisitions -- along with a higher mix of lower-margin restaurant service revenues, rising cloud infrastructure costs, and high onboarding expenses for its new customers -- reduced its adjusted gross margin from 76.2% in 2023 to 55.3% in the first half of 2025. It's also still unprofitable under generally accepted accounting principles (GAAP). So while SoundHound is growing, it hasn't proven that its business model is sustainable yet.

Nevertheless, the bulls expect its gross margins to rise again as economies of scale kick in, its pricing power improves, and it expands its higher-margin software licensing and royalties segment.

The broader buying frenzy in AI stocks could also drive its shares higher. Analysts expect its revenue to grow at a compound annual growth rate (CAGR) of nearly 47% to $267 million from 2024 to 2027. But with a market cap of $7.4 billion, it's already valued at 28 times its projected sales for 2027. That bubbly valuation could set it up for a steep pullback.

Brighter days could be ahead for BigBear.ai
BigBear.ai's three AI modules -- Observe, Orient, and Dominate -- can ingest data, identify trends, and predict future outcomes, respectively. These modules are plugged into edge networks, which intercept the data that flows between origin servers and end users. It also shares that data with bigger data mining companies like Palantir.

Its revenue stayed nearly flat in 2023 and only grew 2% in 2024. It struggled with the bankruptcy of its top customer Virgin Orbit, competition from similar companies, and tough macro headwinds for enterprise software companies. Nevertheless, its gross margin still expanded 240 basis points to 28.6% in 2024 as it gradually stabilized its business.

Under Mandy Long, who took the helm as its CEO in late 2022, BigBear.ai acquired the AI vision firm Pangiam, which developed biometric identity tools for the U.S. government, to diversify its business and grow its revenues. Pangiam's CEO Kevin McAleenan, who previously served as the Acting Secretary of the Department of Homeland Security (DHS) during the first Trump administration, succeeded Long as BigBear.ai's new CEO in early 2025 and focused on gaining more government contracts.

Under McAleenan, BigBear.ai's backlog swelled as it secured new digital ID and biometrics initiatives for the DHS, a modernization project for the U.S. military's Orion Decision Support Platform (DSP), and other supply chain projects. But in the first half of 2025, its revenue still dropped 8% year over year as it dealt with near-term disruptions to its government contracts, and its gross margin shrank 170 basis points to 23.1%. For the full year, analysts expect its revenue to decline 16%.

That near-term outlook seems dim, but analysts expect its revenue to rise 14% in 2026 and 6% to $162 million in 2027 as it converts its backlog into actual revenues. However, it's still expected to stay unprofitable on a GAAP basis. With a market cap of $2.8 billion, it already trades at 17 times its 2027 sales.

The better buy: SoundHound AI
I wouldn't rush to buy either of these stocks right now, since there's a bit too much AI-driven hype baked into their current valuations. But if I had to pick one over the other, I'd buy SoundHound, because it's growing faster, faces fewer direct competitors, and has healthier gross margins. The market's demand for AI-powered voice recognition services should also continue climbing over the next few years as more companies gradually reduce their dependence on human employees.

Leo Sun has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Chipotle Mexican Grill, Mastercard, and Palantir Technologies. The Motley Fool recommends Stellantis and recommends the following options: short December 2025 $45 calls on Chipotle Mexican Grill. The Motley Fool has a disclosure policy.

SummaryThe S&P 500 (SPY) experienced its largest one-day decline since April, driven by technical factors and President Trump's 100% China tariff announcement.Friday's action looked scary, but I have been preparing for this drop and view it as a buying opportunity.A correction targeting the 6343-6372 level should be underway.The broader uptrend from April remains intact, with new highs expected after the pullback. AlexSecret/iStock via Getty Images

The S&P500 (NYSEARCA:SPY) made its largest one-day decline since April on Friday, and fell more after the close as President Trump announced a 100% tariff on China.

Coincidentally (or luckily), on Thursday, I announced on X that I

Analyst’s Disclosure:I/we have a beneficial long position in the shares of VOO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I have a short-term short trade on the SPX (CFD).

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

When it comes to powering the A.I. trade, Nano Nuclear Energy (NNE) president and executive chairman Jay Yu sees his company being well-positioned.

Seneca House Advisors fully exited its position in Diageo (DEO 0.28%), selling 35,043 shares for an estimated $3.53 million in Q3 2025, according to an SEC filing dated October 10, 2025.

What happenedSeneca House Advisors disclosed in a regulatory filing with the Securities and Exchange Commission dated October 10, 2025, that it sold its entire holding in Diageo during the third quarter. The sale involved 35,043 shares, with an estimated transaction value of $3.53 million based on the average market price over the reporting period. The fund now reports no exposure to Diageo.

What else to knowSeneca House Advisors sold out its Diageo position, reducing its exposure from 1.4% of 13F assets to zero.

Top holdings after the filing:

NYSEMKT:RSP: $25.15 million (10.16% of AUM)NASDAQ:GOOGL: $16.39 million (6.60% of AUM) as of 2025-09-30NASDAQ:MSFT: $14.79 million (5.98% of AUM)NYSE:MKL: $14.64 million (5.92% of AUM) as of 2025-09-30NYSEMKT: IBDX: $12.03 million (4.86% of AUM) as of 2025-09-30As of October 9, 2025, shares of Diageo were priced at $95.41, down 29.08% over the past year and underperforming the S&P 500 by 45.04 percentage points.

Company OverviewMetricValueRevenue (TTM)$20.25 billionNet Income (TTM)$2.35 billionDividend Yield4.37%Price (as of market close 2025-10-09)$95.41Company SnapshotDiageo offers a broad portfolio of alcoholic beverages, including Scotch whisky, gin, vodka, rum, tequila, liqueurs, beer, and ready-to-drink products under global brands such as Johnnie Walker, Smirnoff, Guinness, and Baileys.

The company generates revenue primarily through the production, marketing, and sale of branded spirits and beer across diverse international markets. It operates across North America, Europe, Africa, Latin America, the Caribbean, and Asia Pacific.

Diageo is a leading global beverage company with a diversified product portfolio and strong brand recognition.

Foolish takeThis year has been challenging in many ways for Diageo, due to geopolitical factors and industry-wide trends.

Like many other companies, Diageo has been negatively affected by tariff policies. The adult beverage company imports much of its production from Europe and the U.K., and earlier this year, it estimated that tariffs would cost around $150 million in profits.

At the same time, the entire alcoholic beverage industry has been struggling in recent years. Beer and wine sales have been consistently down across the industry, and Americans have reported drinking less than in years past, according to recent polls. If this is only a short-term trend, Diageo could be poised for a lucrative comeback. But if it's a longer-term shift, the company will need to find a way to pivot moving forward.

Glossary13F reportable assets: Assets that institutional investment managers must report quarterly to the SEC, detailing their holdings.
Assets under management (AUM): The total market value of investments managed on behalf of clients by a fund or firm.
Quarterly average price: The average price of a security over a specific quarter, used to estimate transaction values.
Exposure: The amount of capital or percentage of a portfolio invested in a particular asset, sector, or market.
Regulatory filing: Official documents submitted to government agencies, such as the SEC, disclosing financial or operational information.
Dividend yield: A financial ratio showing how much a company pays in dividends each year relative to its share price.
Portfolio: A collection of financial assets, such as stocks, bonds, or funds, held by an investor or institution.
Stake: The ownership interest or share an investor holds in a company or asset.
TTM: The 12-month period ending with the most recent quarterly report.
Underperforming: When an asset delivers lower returns than a benchmark or comparable investments over a period.

Katie Brockman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Markel Group, and Microsoft. The Motley Fool recommends Diageo Plc and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.

NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Snap Inc. (NYSE: SNAP) between April 29, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), both dates inclusive, of the important October 20, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Snap securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Snap class action, go to https://rosenlegal.com/submit-form/?case_id=2663 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 20, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period created the false impression that they possessed reliable information pertaining to Snap’s expected advertising revenue and anticipated growth while emphasizing potential macroeconomic instability. In truth, Snap’s optimistic reports of advertising growth and earnings potential fell short of reality as they relied far too heavily on Snap’s ability to execute on its potential; Snap was already experiencing the ramifications of a significant execution error when defendants’ claimed a lack of visibility due to macroeconomic conditions. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Snap class action, go to https://rosenlegal.com/submit-form/?case_id=2663 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Soleno Therapeutics, Inc. (NASDAQ: SLNO) resulting from allegations that Soleno Therapeutics may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Soleno Therapeutics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=43959 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

WHAT IS THIS ABOUT: On August 15, 2025, Investing.com published a story entitled “Soleno Therapeutics stock falls after Scorpion Capital short report.” The article stated that Soleno Therapeutics stock had fallen “following a short report from Scorpion Capital that raised serious concerns about the company’s recently approved Prader-Willi syndrome treatment, VYKAT XR.” It further stated that the Scorpion Capital report “highlighted personal safety issues,” and that it “suggested the drug may be at risk of being withdrawn from the market or facing a significant decline in new prescriptions.”

On this news, Soleno Therapeutics’ stock fell 7.4% on August 15, 2025. It fell a further 4.9% on the next trading day.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

Robotaxis could become a $10 trillion global opportunity.

Cathie Wood, CEO of Ark Invest, is going all-in on robotaxis. "In our view, 2025 is shaping up to be the year of the robotaxi," a report from her firm recently predicted. "Our research suggests ... safety has improved ~3x since mid-2024 and is approaching the U.S. human accident rate ..."

The massive improvement in safety isn't a coincidence. The autonomous driving industry has aggressively adopted AI technologies, and these heavy investments are clearly paying off. There's one company that should be a clear winner as a result. It's a company that most investors might not think of as an AI business, but by the end of this decade, Wood predicts it will be one of the largest AI companies on the planet.

AI could make this a $2 trillion business by 2026
Wood isn't alone in her bullishness for AI and robotaxis. Dan Ives, an analyst at Wedbush Securities, thinks the combined AI and robotaxi opportunity could create a $2 trillion opportunity by the end of 2026. "We believe the AI Revolution is now heading into its next stage of growth as the tidal wave of Big Tech capex [capital expenditure] spending coupled by enterprise use cases now exploding across verticals is creating a number of AI winners in the tech world," Ives said this week.

One of Ives' top picks just happens to be one of Wood's top portfolio holdings: Tesla (TSLA -4.97%).

"We believe Tesla is taking major steps in advancing its AI Revolution path with autonomous and robotics front and center heading into 2026 that will be a game changer and define Tesla's future," Ives said.

Tesla will have many advantages in the robotaxi market, a market that Wood believes could ultimately be worth $10 trillion globally. One of the biggest is that it can produce its own vehicles, while nearly every other would-be competitor will have to source their vehicles from third parties. This creates structural friction when it comes to scaling and data collection.

Alphabet's self-driving car subsidiary Waymo, for example, plans to add 2,000 vehicles to its robotaxi fleet next year, roughly doubling its size. Tesla, on the other hand, can produce more than 5,000 vehicles daily.

Tesla is in the driver's seat when it comes to robotaxis
When it comes to vertically integrated manufacturing and sheer scaling ability, Tesla is in the driver's seat for capturing market share in the robotaxi space. Importantly, however, the robotaxi opportunity is just taking off. It could take years, or even decades, for Wood's $10 trillion prediction to come true, if it does. Wood, Ives, and even Tesla CEO Elon Musk have long been known for making overly optimistic predictions. But their optimism is usually related to timelines, not necessarily the feasibility of their predictions.

Still, Tesla faces a difficult year ahead. I've written about how demand for electric vehicles could fall off a cliff in 2026. EV producers like Tesla, meanwhile, won't be receiving federal subsidies that formerly totaled in the billions of dollars, nor will their customers be receiving federal tax credits anymore.

But the robotaxi opportunity is large, and investors willing to look past challenging near-term conditions have an opportunity to invest in arguably the best robotaxi stock on the market today.

Ryan Vanzo has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet and Tesla. The Motley Fool has a disclosure policy.

The Caterpillar logo is seen in this illustration taken August 3, 2025. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab

Oct 13 (Reuters) - Australian mining software firm RPMGlobal

(RUL.AX), opens new tab said on Monday that it has struck a deal to be acquired by heavy machinery giant Caterpillar

(CAT.N), opens new tab for a total equity value of A$1.12 billion ($728.22 million).

The news comes after Caterpillar had offered to buy the Australian company at A$5 per share in early September. RPM shares had jumped to a high of near A$4.80 after the news but are last trading at A$4.75.

Sign up here.

RPMGlobal, the last remaining mining software company listed on the ASX, is set to vanish from public markets following its acquisition by Caterpillar.

The move comes after rival Micromine was snapped up by the Weir Group in an A$1.3 billion deal, marking the end of an era for Australia's homegrown mining tech players.

The deal would be closely scrutinized by the Foreign Investment Review Board and Australia's competition regulator and would also require approvals from RPMGlobal's shareholders.

($1 = 1.5380 Australian dollars)

Reporting by Rishav Chatterjee in Bengaluru; editing by Diane Craft

Our Standards: The Thomson Reuters Trust Principles., opens new tab

mRNA-4359 has advanced into the Phase 2 portion of the ongoing Phase 1/2 trial CAMBRIDGE, MA / ACCESS Newswire / October 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that clinical, safety and translational data from its Phase 1/2 study evaluating mRNA-4359 in combination with pembrolizumab in checkpoint inhibitor-resistant/refractory(CPI-R/R) melanoma patients will be presented at the 2025 European Society for Medical Oncology (ESMO) Congress, October 17-21, 2025, in Berlin, Germany. mRNA-4359 is an investigational immune-evasion targeted cancer antigen therapy (CAT) that encodes epitopes of two common immune escape pathways, PD-L1 and IDO1, to elicit antigen-specific T cell responses that may directly kill tumor cells and deplete tumor suppressor cells.

Six oral presentations highlight Signatera’s expanding role across solid tumors, including definitive predictive data in adjuvant bladder cancer

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that 14 studies featuring its technology will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 17–21 in Berlin, Germany. The slate includes six oral presentations, reinforcing Natera’s position as a leader in molecular residual disease (MRD) testing across multiple cancer types.

Bladder Cancer Highlights

The IMvigor011 trial, sponsored by Genentech, a member of the Roche Group, has been selected for a Presidential Symposium on October 20. With positive topline results announced in August, this oral presentation will include additional data on Signatera’s ability to predict disease-free survival (DFS) and overall survival (OS) benefit from adjuvant Tecentriq® (atezolizumab) in muscle-invasive bladder cancer (MIBC). IMvigor011 is the first prospective, phase III study in MIBC to be read out that uses a bespoke MRD-guided approach.

MRD analysis from the Phase 3 CheckMate 274 trial will also be shared in an oral presentation on October 17. CheckMate 274 randomized high-risk MIBC patients 1:1 to Opdivo® (nivolumab) or placebo for ≤ 1 year of adjuvant treatment. The results showed that DFS for Signatera-positive patients treated with nivolumab more than doubled compared to placebo (7.4 months vs 2.8 months; HR: 0.35). In contrast, no significant improvement in DFS was observed with the use of nivolumab among Signatera-negative patients.

Additional ESMO Data

Additional oral presentations include results from the SunRISe-4 trial in MIBC, the INTERCEPT trial in colorectal cancer, and Natera’s early cancer detection program.

“Across multiple different Phase 3 trials, we’ve now shown how Signatera MRD can help identify patients with bladder cancer who are most likely to benefit from adjuvant immunotherapy,” said Matthew Galsky, M.D., Lillian and Howard Stratton Professor of Medicine at the Icahn School of Medicine at Mount Sinai and Associate Director for Translational Research at the Tisch Cancer Center. “These key studies are building a powerful foundation for bespoke MRD to guide different forms of treatment, improve outcomes for patients with bladder cancer and change medical practice.”

“We are proud to showcase the breadth of research using Signatera at this year’s ESMO Congress, including oral presentations across bladder, colorectal, breast, and other cancers,” said Minetta Liu, M.D., chief medical officer of oncology at Natera. “The diversity of these datasets underscores the growing impact of bespoke MRD assessment in reshaping how we detect and monitor cancer, providing tools to personalize treatment recommendations in oncology–with the ultimate goal of improving outcomes for patients.”

Full list of presentations featuring Natera’s technology at ESMO includes:

October 17, 2:50 PM CEST | 3068O (Oral Presentation)

Presenter: Matthew D. Galsky, M.D.

Adjuvant nivolumab vs placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274

October 17, 4:40 PM CEST | LBA 112 (Mini Oral Presentation)

Presenter: Andrea Necchi, M.D.

Neoadjuvant gemcitabine intravesical system (TAR-200) + cetrelimab (CET) or CET alone in patients (pts) with muscle-invasive bladder cancer (MIBC): SunRISe-4 (SR-4) primary analysis and biomarker results

October 18, 9:00 AM CEST | 185eP

Presenter: Michael Galo

Treatment response using a tumor-informed circulating DNA test (TIctDNA) comparing with radiologic outcomes in non-small cell lung cancer (NSCLC)

October 18, 12:00 PM CEST | 1132P

Presenter: Floortje Backes, M.D.

Utility of circulating tumor DNA (ctDNA) dynamics for evaluating early treatment response in patients with recurrent/metastatic endometrial (rEC) and recurrent/platinum-resistant ovarian cancer (rPROC)

October 18, 12:00 PM CEST | 2609P

Presenter: Arnab Basu, MBBS, MPH, FACP, M.D.

Clinical Performance of a Tumor-Informed Whole Genome-Based (WGS) ctDNA Assay for Recurrence Detection and Treatment Response Monitoring in Localized and Advanced/Metastatic Renal Cell Carcinoma (RCC)

October 19, 12:00 PM CEST | 764P

Presenter: Masaaki Miyo, M.D., Ph.D.

Association of ultrasensitive whole genome sequencing (WGS)-based tumor-informed molecular residual disease (MRD) detection with lymph node metastasis (LNM) after local excision of pathological T1 colorectal cancer: Results from DENEB, a CIRCULATE-Japan GALAXY substudy

October 19, 2:45 PM CEST | 734MO (Mini Oral Presentation)

Presenter: Yoshiaki Nakamura, M.D., Ph.D.

Performance of a blood-based, early cancer detection (ECD) screening test for colorectal cancer (CRC) in cell-free (cf)DNA

October 19, 2:50 PM CEST | 732MO (Mini Oral Presentation)

Presenter: Emerick Osterlund, M.D., Ph.D.

Circulating tumor DNA (ctDNA) clearance and correlation with outcome in the INTERCEPT colorectal cancer (CRC) study

October 19, 12:00 PM CEST | 823P

Presenter: Kozo Kataoka, M.D.

A Phase II Study of mFOLFOXIRI Following Metastasectomy in Oligometastatic Colorectal Cancer: (FANTASTIC)

October 19, 3:40 PM CEST | LBA 31 (Oral Presentation)

Presenter: Yara L. Verschoor

Neoadjuvant immunotherapy induces immune activation and responses in MMR-proficient colon cancers

October 20, 12:00 PM CEST | 620TiP

Presenter: Benjamin Verret, M.D.

HEROES: De-escalation of anti-HER2 therapies in HER2-positive metastatic breast cancer with long-term persistent response and undetectable minimal residual disease in circulating tumor DNA

October 20, 12:00 PM CEST | 354P

Presenter: Adrian Lee, Ph.D.

Hormonal and immune mediators of resistance to primary endocrine therapy

October 20, 12:00 PM CEST | 336P

Presenter: Arielle J. Medford, M.D.

Circulating tumor DNA detection in stage 1 HER2 positive and triple negative breast cancer (SAFE-DE)

October 20, 4:30 PM CEST | LBA 8 (Oral Presentation)

Presenter: Thomas B. Powles, MBBS, MRCP, M.D.

IMvigor011: a Phase 3 trial of circulating tumour (ct)DNA-guided adjuvant atezolizumab vs placebo in muscle-invasive bladder cancer

Notes

Tecentriq® (atezolizumab) is a registered trademark of Genentech, a member of the Roche Group.

About Natera

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 300 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

Forward-Looking Statements

All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera’s plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera’s expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to whether the results of clinical or other studies will support the use of our product offerings, the impact of results of such studies, our expectations of the reliability, accuracy, and performance of our tests, or of the benefits of our tests and product offerings to patients, providers, and payers. Additional risks and uncertainties are discussed in greater detail in "Risk Factors" in Natera’s recent filings on Forms 10-K and 10-Q, and in other filings Natera makes with the SEC from time to time. These documents are available at www.natera.com/investors and www.sec.gov.

More News From Natera, Inc.

Sound Income Strategies, LLC disclosed the sale of 177,473 shares of Hercules Capital (HTGC -2.02%) for an estimated $3.40 million in an SEC filing dated October 10, 2025.

What HappenedAccording to a filing with the Securities and Exchange Commission dated October 10, 2025, Sound Income Strategies, LLC reduced its stake in Hercules Capital by 177,473 shares during the quarter ending on September 30, 2025. The estimated transaction value, based on the average closing price for the quarter, was approximately $3.40 million. Following the sale, the fund reported holding 2,752,867 shares at quarter-end.

What Else to KnowThis reduction in the Hercules Capital position now accounts for 2.6% of Sound Income Strategies, LLC's reportable U.S. equity assets.

Top holdings after the filing:

NYSE:TSLX: $50.57 million (2.8% of AUM) as of September 30, 2025NASDAQ:ARCC: $47.33 million (2.6% of AUM) as of September 30, 2025NYSE:HTGC: $46.96 million (2.6% of AUM) as of September 30, 2025NASDAQ:GBDC: $45.58 million (2.5% of AUM) as of September 30, 2025UNK:SHYG: $42.91 million (2.4% of AUM) as of September 30, 2025As of October 9, 2025, shares were priced at $17.06, down 15.17% over the past year. Hercules Capital stock has underperformed the S&P 500 by 23.78 percentage points over the past year.

Company OverviewMetricValueRevenue (TTM)$504 millionNet Income (TTM)$257 millionDividend Yield11.26%Price (as of market close 2025-10-09)$17.06Company SnapshotHercules Capital provides venture debt, senior secured loans, and growth capital, primarily to privately held, venture capital-backed companies across technology, life sciences, and sustainable energy sectors.

The company targets emerging and growth-stage companies in the United States, with a focus on technology, life sciences, and energy technology firms seeking flexible financing solutions.

It serves a customer base of innovative, high-growth companies that require customized funding to support expansion and liquidity needs.

Hercules Capital is a leading provider of specialized financing solutions for innovative, high-growth companies, leveraging structured debt and equity investments to support expansion and liquidity needs. Its competitive advantage lies in deep sector expertise and the ability to deliver customized funding to underserved segments of the venture ecosystem.

Foolish takeSound Income Strategies trimmed its stake in Hercules Capital during the third quarter, selling nearly $3.5 million worth of Hercules stock. That may seem like a very large sale -- and it is by most retail standards -- but for a investment advisory firm like Sound Income, which has more than $1.8 billion in assets under management, this sale represents just an adjustment.

As for Hercules, the stock has endured a difficult 12 months. Shares have posted a total return of (6.2%), which is far worse than the S&P 500 over that same period, which posted a total return of 14.2%. The company, which operates as a key lender to the venture capital ecosystem, appears to have fallen out of favor with the broader market, with shares falling by nearly 15% in the last month alone.

Nonetheless, the average investor shouldn't get the wrong idea about this sale. As of September 30, Sound Income retains more than 2.7 million shares, making Hercules its third-largest position. In other words, this looks like institutional noise, rather than a significant directional call by the fund managers.

Glossary13F AUM: The total value of assets under management reported by institutional investment managers in quarterly SEC Form 13F filings.
AUM (Assets Under Management): The total market value of all investments managed by a fund or investment firm.
Venture debt: Loans provided to early-stage, venture capital-backed companies, often as an alternative or supplement to equity financing.
Senior secured loans: Loans backed by collateral and given repayment priority over other debts if the borrower defaults.
Growth capital: Funding provided to mature companies to expand operations, enter new markets, or finance significant acquisitions.
Dividend yield: Annual dividend income expressed as a percentage of the current share price.
Trailing: Refers to performance or data measured over a past period, often the previous 12 months.
TTM: The 12-month period ending with the most recent quarterly report.
Structured debt: Customized loan arrangements with specific terms, often including features like warrants or convertible options.
Liquidity needs: The requirement for cash or easily accessible funds to meet short-term obligations or opportunities.
Venture capital-backed companies: Firms that have received investment funding from venture capital firms to support growth and development.
Customized funding: Tailored financing solutions designed to meet the unique needs of specific companies or situations.

Jake Lerch has positions in Ares Capital. The Motley Fool has positions in and recommends Sixth Street Specialty Lending. The Motley Fool has a disclosure policy.

A Samsung Electronics logo and a computer motherboard appear in this illustration taken August 25, 2025. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab

SummaryCompaniesSamsung Q3 profit forecast 10.1 trillion won, highest Q3 profit since 2022Profit boosted by conventional memory chips backed by server demandMemory chip gains to offset weaker HBM salesAnalysts warn of China's rare earths curbs, tariff risks despite AI chip dealsQ3 preliminary results expected on Tuesday, October 14SEOUL, Oct 13 (Reuters) - Samsung Electronics

(005930.KS), opens new tab is expected to post its highest third-quarter profit since 2022, driven by higher memory chip prices supported by server demand as customers rebuild inventories, analysts' estimates showed.

The world's biggest maker of memory chips is projected to report an operating profit of 10.1 trillion won ($7.11 billion) for the July-September period, according to LSEG SmartEstimate from 31 analysts, which is weighted toward those who are more consistently accurate. This would be up 10% from a year earlier.

Sign up here.

Analysts attributed the recovery mainly to better conventional memory chip pricing, which would offset weaker sales volumes of high-bandwidth memory (HBM) chips as Samsung has yet to supply its latest HBM products to Nvidia

(NVDA.O), opens new tab.

HBM chips, critical for artificial intelligence (AI) development, are designed to reduce power consumption and process large datasets by stacking chips vertically.

Analysts said demand for memory chips, particularly from hyperscalers and AI-related investments for services such as ChatGPT, have put more workload on general servers, thus boosting conventional memory chip prices.

Prices of some DRAM chips, widely used in servers, smartphones and PCs, jumped 171.8% in the third quarter from a year earlier, according to TrendForce data.

While Samsung's conventional memory business performed well, analysts said delays in supplying its latest 12-layer HBM3E chips to Nvidia have hurt its profit and share price.

Rivals SK Hynix

(000660.KS), opens new tab and Micron

(MU.O), opens new tab have gained more from AI-driven demand, while Samsung's exposure to China, where advanced chip sales are restricted by the United States, has constrained its growth.

Analysts said market sentiment toward Samsung's shares and chip business, including both memory and contract chip manufacturing, is expected to improve as it secures supply deals with major customers such as OpenAI and Tesla

(TSLA.O), opens new tab.

Samsung shares have risen more than 43% following its announcement of a chip supply deal with Tesla in July.

During OpenAI CEO Sam Altman's visit to South Korea earlier this month, Samsung, SK Hynix and OpenAI announced partnerships to supply advanced memory chips to the Stargate project.

The AI chip deal between OpenAI and AMD

(AMD.O), opens new tab, one of Samsung's major HBM customers, would also benefit Samsung, said Ryu Young-ho, a senior analyst at NH Investment & Securities.

Ryu added that Samsung's $16.5 billion foundry deal with Tesla has lifted expectations that Samsung's struggling contract chip manufacturing business could win more orders from major tech firms if the company delivers the project as planned.

While recent AI-driven supply deals signal a positive outlook for Samsung, analysts cautioned that uncertainties remain, including potential U.S. tariffs on chips and China's tightened export controls on rare earth materials used in advanced chips and manufacturing equipment.

In September, Micron said it expects to sell out all of its HBM chips for calendar year 2026 in the coming months due to strong demand.

Samsung will announce its estimates on revenue and operating profit on Tuesday, with full results due later this month.

($1 = 1,420.1000 won)

Reporting by Heekyong Yang; Editing by Jacqueline Wong

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Oct 12, 2025 at 20:37 // Price

Coinidol.com: the price of Bitcoin Cash (BCH) has broken out of its sideways trend, falling below the lower price range of $530.

Bitcoin Cash price long-term analysis: bearish

Since August 12, BCH has been trading between the $530 support and below the $640 resistance, as Coinidol.com wrote. The cryptocurrency reached a low of $474 before recovering.

Today, BCH reversed upwards to reach a high of $540 before pulling back. Buyers are struggling to push the price above the $530 level, which has now become a resistance. BCH is currently trading above the $475 support and below the $540 peak. On the positive side, BCH will resume its upward trend if buyers can sustain the price above the $530 resistance. However, a further decline in the cryptocurrency is unlikely.

Technical Indicators

Key Resistance Zones: $600, $650, $700

Key Support Zones: $500, $450, $400

Bitcoin Cash indicator reading

A long candlestick has broken above the $475 level, indicating strong buying pressure near the $475 support. The price bars are below the horizontal moving average lines. The 21-day SMA is sliding down towards the 50-day SMA support.

BCH/USD daily chart - October 11, 2025

What is the next direction for BCH/USD?

After its decline, BCH has recovered above the $500 support level. The altcoin is currently trading above the $500 support but below the $540 resistance. The $540 barrier is hindering the upward trend. Doji candlesticks have appeared, indicating that price movement has stalled.

BCH/USD 4-hours chart - October 11, 2025

Disclaimer. This analysis and forecast are the personal opinions of the author. The data provided is collected by the author and is not sponsored by any company or token developer. This is not a recommendation to buy or sell cryptocurrency and should not be viewed as an endorsement by CoinIdol.com. Readers should do their research before investing in funds.

Dogecoin (DOGE) has been showing steady gains over recent months, and many traders are now asking: is it too late to buy? According to three widely followed analysts, the technical setup for DOGE remains constructive, provided key support levels hold.

Changpeng Zhao (CZ) jumped to the defense of the BNB token of the BNB Chain and Binance, as some posts have begun to imply foul play as to how the token has defied the negative price influence that swept through the market.

While Ethereum laid down the groundwork for smart contracts,21Shares found that Solana's speed and cheap transactions are driving adoption across a broader spectrum, faster than Ethereum.

Solana’s revenue engine has matured at a pace few in the industry could have anticipated, and has now clearly surpassed Ethereum’s early growth trajectory.

From meme coin mania, DeFi, AI, and RWAs, Solana has managed to capture several on-chain revenue streams that Ethereum couldn’t monetize early, a new report suggests.

Solana’s Early Growth Curve
According to 21Shares, the blockchain generated roughly $2.85 billion in revenue between October 2024 and September 2025, after averaging nearly $240 million per month.

Peaks during periods of intense trading activity were found to be more than $600 million, with January 2025 marking the absolute high point at $616 million. This surge was driven largely by meme coin mania, including coins like Trump Coin. Even after the speculative frenzy cooled, Solana’s monthly revenues have remained in the $150 million-$250 million range. Such sustained figures demonstrated that the chain’s success “is not merely a speculative flash in the pan.”

A closer look at the revenue composition reveals a highly diversified ecosystem. Trading applications such as Photon and Axiom contributed $1.12 billion, or 39% of the total, by facilitating faster swaps, advanced execution, and high-frequency activity.

Beyond trading, Solana’s infrastructure supports a broad spectrum of DeFi, AI, DePin, and tokenized real-world asset applications. Its architecture, capable of thousands of transactions per second at sub-$0.01 costs, has effectively transformed Solana into a 24/7, global “on-chain Nasdaq,” which has helped it rival long-established Web 2 companies like Palantir ($2.8 billion in 2024) and Robinhood ($2.95 billion) in annual revenue.

Perspective Check
The contrast with Ethereum during its formative years couldn’t be more obvious. Between 2019 and 2020, roughly four to five years after Ethereum’s launch, monthly revenue averaged less than $10 million, which is less than 5% of what Solana now produces on a monthly basis.

You may also like:

Ethereum Foundation Assembles 47 Experts for New Privacy Initiative

BNB Meme Coin Frenzy Creates Overnight Millionaires and Costly Mistakes

Ethereum Could Triple to $13,000 This Cycle If History Repeats, Analysts Say

In peak months, Solana’s revenue has outpaced Ethereum’s early numbers by more than 50x. While Ethereum’s growth was constrained by congestion and modest gas fee revenue in a nascent DeFi ecosystem, Solana has leveraged high throughput and low fees to monetize a broader range of activity much earlier in its lifecycle.

Daily active addresses on Solana now consistently hit 1.2-1.5 million, compared to Ethereum’s 400,000-500,000 during its early years.

Solana’s revenue growth has not been linear. 21Shares found that just two years ago, between October 2022 and September 2023, total network revenue stood at a mere $13 million, which can be attributed to early skepticism amid outages and market turbulence. The 220x increase over the past 12 months, however, was a shift from experimental blockchain to a commercially viable ecosystem.

Soon after, institutional interest followed suit. Currently, over $3 billion in SOL is held on public company balance sheets, and multiple treasury initiatives are underway from firms including Forward Industries, Pantera Capital, and Brera Holdings.

Disclaimer

Disclaimer: Blockchain.news provides content for informational purposes only. In no event shall blockchain.news be responsible for any direct, indirect, incidental, or consequential damages arising from the use of, or inability to use, the information provided. This includes, but is not limited to, any loss or damage resulting from decisions made based on the content. Readers should conduct their own research and consult professionals before making financial decisions.

On Sunday, bitcoin ( BTC) climbed to an intraday high of $114,777, marking a nearly 2.7% rebound in 24 hours. The surge reflects renewed confidence and heightened market activity as crypto traders react to shifting economic signals and buying momentum.

Solana (SOL) traders are projecting an uphill run for the asset, driven by the adoption of massive corporate treasuries over the past few weeks. The dominant trend has seen institutional giants and smaller firms pick up crypto assets, diversifying their balance sheets to boost financials. While Bitcoin remains the leader, altcoins like Solana and Ethereum (ETH) have garnered significant institutional support.

Helius Plans 5% Solana Acquisition
Solana digital asset treasury firm Helius plans to purchase 5% the supply valued at over $6 billion. This comes amid increased plans to boost its asset reserves before the end of the year. The healthcare technology company moved towards the asset class and secured $500 million last month.

In a recent interview, Joseph Chee, the company’s Solana treasury, noted that the new purchase will be made after it meets regulatory and capitalization requirements. The company’s goal is to bag as much as 5% of Solana’s supply within six months. It should be noted that for such a deal to pull through, Solana must be shown to meet suitability criteria that meet public interests.

Zhu Junwei, the executive chairman of Helius Solana Company (HSDT), explained that the strategy is a bridge for the flow of funds. He pointed out that the success of a treasury strategy requires proper management to boost financials.

“Financing at a cost of capital lower than one to one, that is, getting something originally worth 100 yuan for 200 yuan, is beneficial to shareholders, and your cryptocurrency per share will always increase,” he added. 

Advertisement
 

This year, traditional firms adopting Solana and other assets have surged, triggering higher prices in the market. Wider sentiments are also at a record level after the market cap broke the $4 trillion mark. A major catalyst for renewed Solana investment is its transaction speed and decentralized finance (DeFi) ecosystem. As more funds flow, bull projects an upward momentum to new highs. 

At the time of writing, Solana trades at $196, a 56% growth over the past year, although monthly trading remains almost sideways. Bulls are also keen on anticipated spot SOL ETFs in the United States to create a new investment window. Like Bitcoin, altcoin ETFs are expected to drive traditional capital to the asset class. Overall, while analysts predict a strong end to Q4 2025, heavy inflows observed in recent weeks could potentially attract long-term whales.

Tether CEO Paolo Ardoino: ‘Bitcoin and Gold Will Outlast Any Other Currency’Paolo Ardoino’s latest comment about bitcoin and gold echoes Tether’s policy of buying BTC with profits and building up gold exposure. Oct 12, 2025, 8:48 p.m.

Tether CEO Paolo Ardoino said in a post on X on Sunday that "Bitcoin and Gold will outlast any other currency," a minimalist line that aligns with how the stablecoin issuer has positioned parts of its reserves over the past two years.

On May 17, 2023, Tether said it would regularly allocate up to 15% of net realized operating profits to purchase bitcoin for reserves, adding BTC to surplus rather than using it to back circulating USDT one-for-one. The company framed the move as strengthening its balance sheet with a long-term store of value.

STORY CONTINUES BELOW

BTC and gold as parallel pillarsGold sits alongside bitcoin in that mix.

Tether issues tether gold (XAUt), a token backed by allocated bars, and said on July 24 that more than 7.66 tons of metal backed outstanding tokens as of June 30, 2025. Separately, as CoinDesk reported on Sept. 5, 2025, citing the Financial Times, Tether has held talks to invest across the gold value chain — from mining and refining to royalties — as part of a broader diversification push.

Ardoino has grouped the assets rhetorically before. On Sept. 7, he referenced bitcoin, gold and land as hedges and later dismissed suggestions that Tether sold BTC to accumulate gold, saying the firm remained committed to growing its bitcoin position.

Today's eight-word post is less a policy shift than a restatement — bitcoin as a strategic asset added with profits, and gold as a parallel pillar via tokenization and potential upstream investments — while most reserves remain in liquid instruments such as U.S. Treasurys per attestations. The next reserve report, expected late this month or early next month, will show whether allocations to BTC and gold have changed.

As of Sunday, 8:10 p.m. UTC, the U.S. dollar index (DXY) was down 8.88% year to date, while bitcoin and gold — BTC-USD and XAU-USD — were up 22.79% and 52.91%, respectively, according to MarketWatch.

AI Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

Mais para você

Total Crypto Trading Volume Hits Yearly High of $9.72T

9 de set. de 2025

Combined spot and derivatives trading on centralized exchanges surged 7.58% to $9.72 trillion in August, marking the highest monthly volume of 2025

O que saber:

Combined spot and derivatives trading on centralized exchanges surged 7.58% to $9.72 trillion in August, marking the highest monthly volume of 2025Gate exchange emerged as major player with 98.9% volume surge to $746 billion, overtaking Bitget to become fourth-largest platformOpen interest across centralized derivatives exchanges rose 4.92% to $187 billionView Full Report

Mais para você

Altcoins Cratered in Oct. 10 Crypto Flash Crash as Bitcoin Held Up, Wiston Capital Says

há 3 horas

Wiston Capital's Charlie Erith says a leverage cascade drove the Oct. 10 break, with altcoins hit hardest, and lays out the signals he will track before adding risk.

O que saber:

About $560 billion (13.1%) has come off total crypto market value since Oct. 6, Wiston Capital Founder Charlie Erith says.Tokens excluding bitcoin, ether and stablecoins fell about 33% in roughly 25 minutes during the break, alongside approximately $18.7 billion in liquidations, he says.He is watching bitcoin’s 365-day EMA, bitcoin dominance, Strategy’s trend and the VIX, while staying invested but not levered.Leia a história completa